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LIPOLYTIC ACTIVITY OF STAPHYLOCOCCUS ALBUS*
RONALD M. REISNER, M.D.t AND MADLI PUHVEL, PH.D.1
ABSTRACT
Several indirect lines of evidence have converged to suggest that C. acnes and S. alb'us are
sources of lipolytic enzymes in the piosebaceous follicle and sebaceous duct, resulting in the
liberation of free fatty acids, a process thought to be highly significant in the pathogenesis
of acne. Direct experimental confirmation of the previously inferred role of S. albu.s has been
obtained by incubation of known pure triglycerides with B. albus, and subsequent analysis
of the resultant product with thin layer chromatography. In this in vitro system S. albus has
been clearly demonstrated to have the capacity to cleave triglycerides resulting in the libera-
tion of free fatty acids. These results are similar to those obtained in our previous studies
with C. acnes.
In a previous paper (1) we reviewed the in-
direct evidence suggesting the probable role of
Corynebacterium acnes as a source of lipolytic
enzymes responsible for the formation of free
fatty acids in human surface lipid by cleavage of
fatty acids from the triglycerides of newly
formed sebum (2—6). Direct experimental con-
firmation of this previously inferred role of C.
acns was then obtained by in vitro incubation
of known pure triglycerides with C. acnes and
subsequent analysis of the resultant product
with thin layer chromatography. In this in
vitro system C. acnes was clearly demonstrated
to have the capacity to cleave triglycerides re-
sulting in the liberation of free fatty acids.
The present study was undertaken as part of
a systematic survey to determine whether other
members of the cutaneous microfiora possess
lipolytic enzymes capable of hydrolyzing tri-
glycerides to release free fatty acids. For this
study, 5 short to long chain saturated triglycer-
ides were chosen: tricaprylin, tricaprin, trilau-
nfl, trimyristin, and tripalmitin, and 2 unsatu-
rated triglycerides: tripalmitolein and triolein.
MATERIALS AND METHODS
1. Thin layer chromatography plates—silica gel,
pre-coated, abrasion resistant, 20 x 20 cm from
Brinkman Instrument, Inc. Westbury, New York.
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2. 2',7'-dichlorofiuorescein from Eastman Or-
ganic Chemicals.
3. 2,2, 4-trimethylpentane (iso-octane), b. 98.55—
99.5° C. and iso-propyl acetate, b. 86.5—88.5° C.
both from Matheson, Coleman, and Bell.
4. Chloroform and methanol-reagent grade
from Merck.
5. (a) Triglycerides: tricaprylin, tricaprin, tn-
launin, trimyristin, tripalmitin, tripalmitolein and
tniolein. (b) Diglycerides: dimyristin, dipalmitin,
and diolein. (c) Monoglycerides: monomyristin,
monopalmitin and monoolein. (d) Fatty acids:
caprylie, capric, laurie, myristic, palmitic, palmito-
leic, and oleic (all from Applied Science Labora-
tories, Inglewood, California). All lipid standards
were prepared in glass distilled chloroform: metha-
nol (2:lv/v).
A basal medium was prepared for use in all
growth studies. This consisted of 1% peptone
(Bacto) and 0.5% yeast extract (Difco) in dis-
tilled water. Medium was distributed in 2 ml
amounts into ether rinsed screw cap test tubes, and
autoclaved at 15 lbs. pressure for 15 minutes.
All triglycerides were rechecked for purity in
our laboratory by thin layer chromatography be-
fore further use. Tnicaprylin, tripalmitolein, and
triolein, all liquids at room temperature, were in-
corporated in the amount of 2 mg of triglyceride
per 2 ml tube of room temperature medium. Those
triglycerides which are solid at room tempera-
ture—tricaprin, trilaurin, tnimyristin, and tnipalmi-
tin—were first suspended in acetone at room
temperature, and then added dropwise to boiling
medium to a total amount of 2 mg of triglyceride
per 2 ml tube of medium.
Staphylococcus aibus strains used in this study
were obtained from comedones expressed from the
nose or forehead of patients with acne vulganis.
Primary cultures were made anaerobically on
Brain Heart Infusion Agar (Difco) supplemented
with 1% dextrose. This medium and method of
incubation is used routinely in our laboratory for
the isolation of both Staphylococci and Corynebac-
teria from the skin. After gram staining, presump-
tive S. albws colonies were identified and sub-
grouped according to the Baird-Parker scheme
(7). These gram positive cocci were coagulase
negative, catalase positive, fermented dextrose
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anaerobically, fermented lactose, maltose, glyc-
erol and mannitol aerobically, and were phosphate
negative, and thus met the criteria of Baird-Parker
for Staphylococcus sub-group VI. Cultures of S.
albus grown in Brain Heart Infusion Broth (Difco)
with constant shaking for 6 hours were used as
inocula. Organisms were harvested and washed
twice with sterile distilled water. The suspensions
were standardized with distilled water to a final
optical density of 80 in the Coleman Jr. spectro-
photometer at 420 lambda. One tenth ml of S.
a.lbus suspension was inoculated into each tube.
Controls of sterile basal media without triglycer-
ides, sterile basal media with triglycerides, and
inoculated basal media without triglycerides were
included in each experiment. Tubes were incu-
bated aerobically at 37° C. on a shaker for 24
hours.
Following incubation, the culture tubes were
agitated to obtain even dispersion, and the con-
tents transferred to glass stoppered extraction
tubes. Five volumes of chloroform:methanol (2:1)
were added to each extraction tube. After vigorous
shaking for approximately 2 minutes, the tubes
were centrifuged and the aqueous portion dis-
carded. The residual organic solvent phase was
transferred to a clean glass stoppered tube, and
stored for approximately 4 hours at 15° C. We
have noted that this step greatly facilitates re-
moval of unwanted aqueous residues, and yields
clean, clear solvent phases.
The solvent was then evaporated at room tem-
perature in a stream of nitrogen to a volume of
approximately 0.1 ml. This was streaked on TLC
plates.
The one dimensional plates were developed first
in iso-octane: isopropyl acetate (50:30) until the
solvent front was approximately 2 cm from the
top of the plate. The plate was then removed and
air dried for 15 minutes. It was then rerun in the
same solvent system to the same solvent front.
This double development resulted in improved
separation. The two dimensional plates were de-
veloped first in chloroform 95, methanol 5, and
ammonia Al8 until the solvent front moved within
4 cm of the top of the plate. The plate was then
dried at room temperature for 15 minutes and
turned 90° and developed in chloroform 8, acetone
Fra. 1. TLC plate 12—Incubation of S. albus with trilaurin. 0-origin, SF-solvent front.
Lane 1—Basal medium plus trilaurin after incubation; Lane 2—Basal medium plus trilaurin
plus S. albus (isolate S-i); after incubation; Lane 3—Basal medium plus trilaurin plus
S. albus (isolate 5-2) after incubation; Lane 4—Standard: trilaurin 100 meg (TG),
dimyristin 100 meg (DG), laurie acid 100 mcg (FFA), monornyristin 100 meg (MG),
lecithin 100 mcg (0). (Doubly developed in iso-octane: iso-propyl acetate, (50:30).)
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FIG. 2. TLC plate i'14—Incubation of S. albu with triinyristin. 0-origin SF-solvent
front. Lane 1—Basal medium plus trilnyristin after incubation; Lane 2—Bc sal medium
plus trimyristin plus S. albus (isolate S-i) after incubation; Lane 3—Basal medium plus
trimyristin, plus S. albs (isolate S-2) after incubation; Lane 4—Standard: trimyristin
100 mcg (TG), dimyristin 100 mcg (DG), myristic acid 100 mcg (FFA), monomyristin
100 mcg (MG), lecithin 100 meg (0). An unidentified fluorescent spot appears just below
the triglyceride standard in lane 4. (Doubly developed in iso-octane:iso-propyl acetate,
(50:30).)
1.5, methanol 025, acetic acid 0.25, and water 0.8
until the solvent front was within 4 cm of the top
of the plate.
In the one dimensional plates, one lane of each
plate consists of known standard lipid components
for identification. Additional lanes were run for
extracts of media alone, extracts of individual
triglycerides and media mixed, and extracts of
bacteria and media mixed, to serve as controls.
Plates were then sprayed with 02% 2',7' di-
chlorofiuoreseein in ethanol for visualization of the
lipids, and photographed in ultraviolet light in
the Chromato-Vue made by Ultraviolet Light
Products of San Gabriel, California, utilizing
Kodalith Ortho film at f 5.6 for 10 seconds, and
developed for 1 minute in Dektol.
RESULTS
Unless otherwise specifically noted, extracts
cited in this section are chloroform :methanol
(2:1) extracts, and all TLC plates are doubly de-
veloped in iso-octane: isopropyl acetate (50 30).
As noted previously (1) control plates dem-
onstrated the absence of free fatty acids in ex-
tracts of sterile basal media and basal media
inoculated with S. albus, thus serving as control
observations for the experimental plates in
which various triglycerides are incorporated in
basal media inoculated with S. aibus. A station-
ary, nonfluorescent spot is present at the point
of origin in all lanes containing medium. Due to
slight variations in photographic technique, it
is clearly visible in plate XIV (Fig. 2), visible
with difficulty in plate XII (Fig. 1) and not
visible although present in plate XVI (Fig. 3).
The lipid standards (lane 4 in all plates) move
in ascending order as follows:
Phospholipids (0), monoglycerides (MG),
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Fic. 3. TLC plate 16—Incubation of S. albus with tripalmitolein. 0-origin, SF-solvent
front. Lane 1—Basal medium plus tripalmitolein after incubation; Lane i—Basal medium
plus tripalmitolein plus 2. atbus (isolate S-i) after incubation; Lane s—Basal medium plus
tripalmitolein plus S. albws (isolate S-2) after incubation; Lane 4—Standard: tripalmito-
lein 100 meg (TG), dipalmitin 100 meg (DG), palmitoleic acid 100 meg (FFA), mono-
palmitin iOO meg (MG), lecithin 100 meg (0). (Doubly developed in iso-octane:iso-
propyl acetate, (50:30).)
free fatty acid (FFA), diglycerides (DG), with
the characteristic double spot representing the
1,3 and 1,2 structures, and triglycerides (TG).
TLC plate XII shown in Fig. 1 demonstrates
the lipolytic activity of S. albus acting on a
saturated triglyceride, trilaurin, to release a free
fatty acid.
TLC plate XIV shown in Figure 2 is another
representative plate demonstrating the capacity
of S. albus to hydrolyze a longer straight chain
saturated triglyceride trimyristin, to release free
fatty acids.
TLC plate XVI shown in Figure 3 demon-
strates the lipolytic capacity of S. albus in liber-
ating free fatty acid from a longer straight chain
unsaturated triglyceride, tripalmitolein. The
presence of a fluorescent spot in lane 2 and 3
migrating at RF of the monoglyceride standard
suggests the possibility that in this experiment,
the lipolytic enzymes available from 8. albus
were insufficient to completely hydrolyze all
fatty acid molecules from the glycerol skeleton,
thus leaving some molecules from which only 2
free fatty acids had been cleaved resulting in
the presence of a monoglyceride.
The leading edge of the FFA spot in lanes 2
and 3 of plate XII, lanes 2 and 3 of plate XIV,
and lane 3 of plate XVI migrate beyond the
FFA standard. Our TLC studies with varying
concentrations of single free fatty acids and
with mixtures of FFA demonstrate that these
differences in RF in this system can be a func-
tion of either concentration or composition. Fig-
ure 4 demonstrates the effect of concentration
on RF. Myristie acid was streaked at the origin
in concentrations varying from 10 to 1000 meg
and the resultant increasing RF values can be
clearly seen. Figure 5 demonstrates the effect of
composition on RF. A series of free fatty acids
of ascending molecular weight was streaked at
the origin in lanes 1 through 5 in equal amounts
of 100 meg each. Lane 6 represents 20 meg each
of the FFA in lanes 1 through 5, a total of 100
meg. Clearcut differences in migration are visible.
Whether the alterations in RF value observed
(Figs. 1—3) represent differences in composition
of the various FFA derived from lipolysis of
triglycerides is being subjected to further study,
since degradation to form FFA of shorter chain
lengths is potentially significant in the pathogen-
esis of acne.
Utilizing the 2 dimensional method developed
by Dr. George Rouser as described in Methods
above, spots corresponding to the FFA stand-
ard were scraped off a 1 dimensional TLC plate,
extracted with chloroform : methanol (2:1), and
the identity of the FFA confirmed by 2 dimen-
sional chromatography.
In addition to the representative TLC plates
shown in Figures 1, 2, and 3 in which the effect
of the incubation of S. albus with trilaurin, tn-
myristin, and tripalmitolein in releasing free
fatty acids from triglycerides was demonstrated,
similar experiments with tricaprylin, tricaprin,
tripalmitin, and triolein, were carried out with
similar results. In each case free fatty acids were
clearly shown to be liberated from the pure tri-
glyceride after incubation with S. albus.
DiSCUSSION
This preliminary study has clearly demon-
strated the capacity of S. albus (Staphylococcus
sub-group VT-Baird-Parker) to cleave in vitro
a series of triglycerides resulting in the libera-
tion of free fatty acids. The triglycerides chosen
in this initial study were 5 short to long chain
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FIG. 4. Effect of concentration on RF—Myristic acid. 0-origin, SF-solvent front. Lane
1—Myristic acid 10 meg; Lane 2—Myristic acid 50 mcg; Lane 8—Myristic acid 100 meg;
Lane 4—Myristic acid 250 meg; Lane 5—Myristic acid 500 meg; Lone 6—Myristic acid
1000 meg. (Doubly developed in iso-octane :iso-propyl acetate, (50:30).)
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Fm. 5. Effect of composition on RF. 0-origin, SF-solvent front. Lane 1—Caprylic acid
100 meg; Lane 2—Laurie acid 100 meg; Lane 3—Myristic acid 100 mcg; Lane 4—Palmitoleic
acid 100 meg; Lane 5—Oleic acid 100 meg; Lane 6—A mixture of 20 meg of each of the
5 above FFA. (Doubly developed in iso-octane: iso-propyl acetate, (50:30).)
saturated triglycerides and 2 straight chain un-
saturated triglycerides. These findings were in
the process of being written up when an inde-
pendent report by Dr. Ruth Freinkel (9) was
published also describing the lipolytic activity of
Staphylococcus albus. The lipids used in that
study were olive oil, which is composed of mixed
glycerides of oleic acid, 83.5%, of palmitic acid,
9.4%, of linoleic acid, 4%, of stearic acid, 2%, of
arachidic acid, 0.9%, and squalene, up to 0.7%,
phytosterol and tocopherols about 0.2% and an
unidentified lipid used in a spirit blue indicator
system (Difco). Further study will be necessary
to clarify the exact spectrum of lipolytic activity
of S. albus and identify any variations in glyc..
erides attacked as well as any preferential order
of degradation.
The studies reported in this paper are with 2
isolates of S. albus isolated from patients with
acne. Although no obvious differences in lipolytic
activity were observed in vitro under the condi-
tions of this experiment, the possibility still re-
mains that various strains may possess differing
lipolytic activity, and might thus possibly have
different degrees of pathogenicity in terms of
acneigenesis. Further, the precise patterns of
lipolytic activity of individual strains may vary,
resulting in the production of different patterns
of composition of free fatty acids. In view of
the probable differing degrees of irritancy of
various free fatty acids, this may be a signifi-
cant factor. Further studies utilizing gas chro-
matography to analyze in detail the free fatty
acids identified by TLC are now under way.
These experiments coupled with the previously
reported ones (1) clearly demonstrate the lipo-
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lytic activity of S. albus and C. acnes. Addi-
tional studies are needed to determine the rela-
tive significance of these sources of lipolytic
enzymes in the sebaceous duct and the piloseba-
ceous follicle as opposed to those derived from
other organisms present including Pit yrosporum
species (10), Demodex folliculorum, and other
bacteria, particularly the lipophilic diphtheroids,
as well as endogenous lipolytic enzymes if any.
Studies to evaluate the role of these organisms
are now under way, and initial results indicate
that both Pit yrosporum ovale (10) and the
lipophilie diptheroids (11) possess similar lipo-
lytic enzymes.
However, as noted previously (1) there is
evidence suggesting that both C. aenes and S.
albus are important sources of lipolytic activity
in the sebaceous duct and the pilosebaceous fol-
licle. The administration of tetracycline systemi-
cally results in a striking reduction in the con-
centration of free fatty acids in sebum, which
can be correlated with improvement of clinical
acne (5). This reduction in the concentration
of free fatty acids is well established by the end
of the 3rd week of tetracycline therapy. Upon
discontinuation of therapy there is a trend to-
ward resumption of pre-treatment levels of free
fatty acids. This trend is evident during the
first 3 week period after cessation of treatment.
These observations correlate well with the 2
weeks required for the marked drop in the
density of C. acnes and S. albus observed after
the initiation of tetracycline therapy and with
the 2 weeks required for the return to normal
density after the discontinuation of tetracycline
therapy (12). These observations coupled with
the evidence for the lipolytic activity for C.
aenes and S. albus, would suggest that these
organisms may be an important source of
lipolytic activity in the in vivo situation. How-
ever, other sources such as Pit yrosporum ovale
are also likely to be present to account for the
fact that tetracycline therapy results iii only
about a 50% reduction in sebum FFA (5, 10).
SUMMARY
Staphylococcus albus has been demonstrated
to have the capacity to cleave triglycerides in
vitro, resulting in the liberation of free fatty
acids. This, coupled with previous evidence re-
garding the role of C. acnes gives direct experi-
mental confirmation to the role of these 2 or-
ganisms as sources of lipolytic activity of the
sebaceous duct and pilosebaceous follicle. Study
is now under way to evaluate the role and rela-
tive significance of other cutaneous microflora
as sources of lipolytic activity.
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